Figure 4From: Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinibFinal Kaplan-Meier estimate of time to progression (TTP) and overall survival (OS) in patients stratified by above/below median baseline levels of VEGF-C.Back to article page